A phase II study of induction followed by intermittent duvelisib dosing in patients with chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL).
| Autor: | Shouse G; City of Hope National Medical Center, CA, USA., Chen L; City of Hope National Medical Center, CA, USA., Siddiqi T; City of Hope National Medical Center, CA, USA., Muir A; City of Hope National Medical Center, CA, USA., Brown JR; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Spurgeon SE; The Knight Cancer Institute, Oregon Health and Science University, Portland, OR, USA., Danilov AV; City of Hope National Medical Center, CA, USA. |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | Leukemia & lymphoma [Leuk Lymphoma] 2024 Oct; Vol. 65 (10), pp. 1516-1519. Date of Electronic Publication: 2024 Jun 05. |
| DOI: | 10.1080/10428194.2024.2361841 |
| Databáze: | MEDLINE |
| Externí odkaz: |
|